Latest News
Novartis blood disorder drug shows promise in late-stage trial
Novartis has reported that its experimental drug ianalumab met the primary goal in a phase 3 trial for primary immune thrombocytopenia (ITP), a rare a...
Fertile ground
Top-rated pharmacies in northern Virginia for personalised fertility care Top-rated pharmacies in northern Virginia for personalised fertility care
FDA grants Breakthrough Therapy Designation to lung cancer therapy
The US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) to izalontamab brengitecan (iza-bren), an investigational...
Upperton Pharma Solutions awarded grant to develop oral vaccine delivery with University of Oxford
Upperton Pharma Solutions has been awarded funding under the first VaxHub Sustainable Platform Funding Call to support the development of oral formula...
Friends of Cancer Research and MMS partner to improve interpretation of cancer trial survival data
Friends of Cancer Research has announced a new collaboration with global clinical research organisation, MMS, to develop decision frameworks that will...
ANGLE partners with Myriad Genetics to explore blood-based cancer testing
ANGLE has announced a collaboration with Myriad Genetics to assess whether circulating tumour cell (CTC) DNA harvested from blood samples using ANGLE’...
Mounjaro shows cardiovascular benefit in head-to-head diabetes trial
Lilly’s study finds tirzepatide delivers broader health improvements Lilly’s study finds tirzepatide delivers broader health improvements
Vedanta’s ulcerative colitis candidate misses phase 2 efficacy target
Company shifts focus to phase 3 VE303 trial in recurrent C. difficile infection Company shifts focus to phase 3 VE303 trial in recurrent C. difficile...
Upperton and Oxford join forces to develop oral vaccine formulation
Project aims to improve global immunisation through needle-free delivery Project aims to improve global immunisation through needle-free delivery
Ogsiveo approved in EU for treatment of desmoid tumors
Merck’s therapy becomes first authorised option for aggressive soft tissue tumours Merck’s therapy becomes first authorised option for aggressive soft...
Novartis blood disorder drug shows promise in late-stage trial
Fertile ground
FDA grants Breakthrough Therapy Designation to lung cancer therapy
Upperton Pharma Solutions awarded grant to develop oral vaccine delivery with University of Oxford
Friends of Cancer Research and MMS partner to improve interpretation of cancer trial survival data
ANGLE partners with Myriad Genetics to explore blood-based cancer testing
Mounjaro shows cardiovascular benefit in head-to-head diabetes trial
Vedanta’s ulcerative colitis candidate misses phase 2 efficacy target
Upperton and Oxford join forces to develop oral vaccine formulation
Ogsiveo approved in EU for treatment of desmoid tumors
Advertisement
300x250 Banner
Recent Content
COPD Biologics: Early Treatment Insights
Pulmonology • 2 hours ago
Antihypertensive Medication Guidelines
Cardiology • 4 hours ago
Juvenile Arthritis Care Transition
Rheumatology • 6 hours ago